Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy
Clinical trial NCT06994468 · COMPLETED
Trial details
- NCT number
- NCT06994468
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2025-12-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.